or Try an Advanced Search...

    Technical Analysis for ANVS - Annovis Bio, Inc.

    Grade Last Price % Change Price Change
    F 6.55 9.17% 0.55
    ANVS closed up 9.17 percent on Friday, May 31, 2024, on approximately normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    Earnings due: Jun 12
    *** please verify all earnings dates ***
    3 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical ANVS trend table...
    Date Alert Name Type % Chg
    20 DMA Resistance Bearish 0.00%
    Bullish Engulfing Bullish 0.00%
    Pocket Pivot Bullish Swing Setup 0.00%
    Stochastic Reached Oversold Weakness 0.00%
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    MACD Bearish Signal Line Cross Bearish 9.17%
    NR7 Range Contraction 9.17%
    Narrow Range Bar Range Contraction 9.17%
    Wide Bands Range Expansion 9.17%
    Older End-of-Day Signals for ANVS ...

       Recent Intraday Alerts

    Alert Time
    20 DMA Resistance 1 day ago
    Possible Pocket Pivot 1 day ago
    Rose Above 10 DMA 1 day ago
    10 DMA Resistance 1 day ago
    Up 1 ATR 1 day ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    ANVS Chart by TradingView
    Basic chart:

    Profile

    Annovis Bio, Inc. develops drugs for Alzheimer's and Parkinson's diseases and other neurodegenerative disorders. It offers posiphen compound for mild cognitive impairment and early stage Alzheimer's disease and bisnorcymserine compound that inhibits amyloid formation and prevents the progression of the Alzheimer's disease. The company was founded by Maria Luisa Maccecchini in May 2008 and is headquartered in Berwyn, PA.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Organ Systems Alzheimer's Disease Parkinson's Disease Psychiatric Diagnosis Amyloid Nervous System Neurodegeneration Neurodegenerative Disorders Cognitive Disorders Cognitive Impairment Learning Disabilities Neuroprotection Early Stage Alzheimer's Disease Gladstone Institutes

    Is ANVS a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 29 Peering Into Annovis Bio's Recent Short Interest
    May 28 Wall Street Analysts Think Annovis Bio (ANVS) Could Surge 359.53%: Read This Before Placing a Bet
    May 24 Verastem (VSTM) Up on Upbeat Early Pancreatic Cancer Study Data
    May 24 Bicycle Therapeutics (BCYC) Up as PIPE Funding Set to Make $555M
    May 23 Deciphera's (DCPH) Shares Surge 74.3% in a Month: Here's Why
    May 21 Annovis Announces New Publication in a Peer-Reviewed Journal
    May 17 Amgen's (AMGN) Tarlatamab Receives FDA Approval for SCLC
    May 16 Kodiak (KOD) Q1 Loss Narrower Than Expected, Pipeline in Focus
    May 13 Annovis Bio GAAP EPS of -$0.10 beats by $0.53
    May 13 Annovis Bio Provides Corporate Updates and Announces First Quarter 2024 Financial Results
    See more ANVS news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 22.49
    52 Week Low 4.79
    Average Volume 616,836
    200-Day Moving Average 9.91
    50-Day Moving Average 9.30
    20-Day Moving Average 6.86
    10-Day Moving Average 7.25
    Average True Range 1.23
    RSI (14) 43.82
    ADX 13.69
    +DI 31.90
    -DI 26.29
    Chandelier Exit (Long, 3 ATRs) 6.70
    Chandelier Exit (Short, 3 ATRs) 8.49
    Upper Bollinger Bands 9.31
    Lower Bollinger Band 4.41
    Percent B (%b) 0.44
    BandWidth 71.53
    MACD Line -0.67
    MACD Signal Line -0.65
    MACD Histogram -0.0165
    Fundamentals Value
    Market Cap 69.3 Million
    Num Shares 10.6 Million
    EPS -4.84
    Price-to-Earnings (P/E) Ratio -1.35
    Price-to-Sales 0.00
    Price-to-Book 17.40
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 8.80
    Resistance 3 (R3) 8.87 8.18 8.43
    Resistance 2 (R2) 8.18 7.61 8.15 8.30
    Resistance 1 (R1) 7.37 7.26 7.78 7.30 8.17
    Pivot Point 6.68 6.68 6.89 6.65 6.68
    Support 1 (S1) 5.87 6.11 6.28 5.80 4.93
    Support 2 (S2) 5.18 5.76 5.15 4.80
    Support 3 (S3) 4.37 5.18 4.68
    Support 4 (S4) 4.30